Otonomy, Inc.
OTIC
OTIC was delisted on the 22nd of December, 2022.
55 hedge funds and large institutions have $64.5M invested in Otonomy, Inc. in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 19 reducing their positions, and 14 closing their positions.
1,661% more call options, than puts
Call options by funds: $2.22M | Put options by funds: $126K
7% less funds holding
Funds holding: 59 → 55 (-4)
21% less capital invested
Capital invested by funds: $81.7M → $64.5M (-$17.2M)
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
58% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$2.77M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.1M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$848K |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$800K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$667K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$7.25M |
| 2 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$2.79M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$718K |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
-$655K |
| 5 |
JGC
J. Goldman & Co
New York
|
-$592K |
OTIC Hedge Fund Activity: Q3 2021 in Review
55 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Otonomy, Inc. (OTIC) for Q3 2021, worth a combined $64.5M — down 21% from $81.7M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of OTIC and 10 opened new positions — a net loss of 4 holders — while 19 trimmed existing stakes and 8 added.
The largest buyer was RA Capital Management, opening a new position worth an estimated $2.77M. The largest seller was OrbiMed, exiting entirely with an estimated $7.25M sold.
- 55 institutional investors held Otonomy, Inc. (OTIC) as of Q3 2021, down from 59 in Q2 2021.
- Funds reported $64.5M of Otonomy, Inc. stock for Q3 2021, down 21% quarter-over-quarter.
- 10 funds opened new Otonomy, Inc. positions in Q3 2021 and 14 closed out, a net change of -4 holders.
- The largest Otonomy, Inc. buyer in Q3 2021 was RA Capital Management, an estimated $2.77M added.
- The largest Otonomy, Inc. seller in Q3 2021 was OrbiMed, an estimated $7.25M sold.
Based on aggregated 13F filings for Q3 2021.